YOU ARE HERE: LAT HomeCollectionsVaccines


May 8, 1987 | From Reuters
One million doses of yellow fever vaccine arrived Thursday in Lagos to help combat an outbreak of the disease in western Nigeria that has claimed 140 lives, an aid official said.
July 18, 2008 | From Times Wire Reports
Plans for a large-scale trial of a potential AIDS vaccine are being dropped in favor of a smaller, more focused study, the National Institutes of Health said. The trial of the vaccine, developed by the Vaccine Research Center at the National Institute of Allergy and Infectious Disease, had been planned to include 2,400 men in the United States. However, the agency said it decided that the vaccine did not warrant a trial of that size and scope. The agency will plan a smaller, more focused clinical trial to test the vaccine's effectiveness.
January 15, 1999 | From Times Wire Reports
A vaccine that attacks HIV at a vulnerable moment of the deadly virus' infection cycle has been shown to be effective in laboratory tests, researchers say. In studies at the University of Montana, researchers developed antibodies in mice that attacked HIV, the virus that causes AIDS, just as the virus was in the process of fusing with target cells. A report on the study is being published today in the journal Science.
March 25, 1999 | Reuters
Researchers said Wednesday that they have used DNA from the parasite that causes malaria to produce a vaccine that they hope will prevent the disease. The new vaccine uses bits of the DNA to stop the parasite's growth in the bloodstream and should stop transmission of the infection, the researchers at the Johns Hopkins School of Public Health in Baltimore said. They wrote about their discovery in the April issue of the journal Infection and Immunity.
December 11, 2002 | Charles Ornstein, Times Staff Writer
Los Angeles County health officials have pared their request to the federal government for smallpox vaccine after refining their preparations for possible bioterrorism. The county Department of Health Services this week asked for 9,190 doses of the vaccine, primarily for hospital emergency room workers. Just one week ago, county health officials had said they would seek up to 20,000 doses from the U.S. Centers for Disease Control and Prevention. Dr.
March 11, 1988
Scientists reported encouraging results Thursday in the first human tests of an experimental vaccine that fights a malaria-causing parasite at the stage when it infects red blood cells. Studies in young men found that the experimental inoculation delayed or suppressed the development of the disease, Colombian scientists reported in Thursday's issue of the British journal Nature.
May 29, 2003 | From Associated Press
A military panel found an Army reservist guilty of disobeying an order for refusing to take the anthrax vaccine and tossed her out of the Army on Wednesday. The panel of eight officers -- only two of whom said during questioning that they have taken the six-shot regimen -- took 40 minutes to return a guilty verdict against Pvt. Kamila Iwanowska and two hours to determine her penalty: a bad conduct discharge.
July 21, 2005 | Denise Gellene, Times Staff Writer
The outlook for Chiron Corp.'s flu vaccine business worsened Wednesday when the company said it would ship no vaccine from a troubled German factory. The announcement came five days after Chiron slashed production at the Marburg plant after finding bacteria in some vaccine. On Wall Street, the latest round of bad news fueled uncertainty about Chiron's ability to supply vaccine to the United States.
California and other states could save millions of dollars by buying vaccines in bulk and distributing them to physicians who treat children eligible for Medicaid, the Children's Defense Fund, an advocacy group, said Monday.
December 1, 1992 | Reuters
The National Institutes of Health announced Monday it will permit tests in humans of two potential vaccines for AIDS developed by Genentech Inc. and Biocine, a joint venture of Ciba-Geigy AG and Chiron Corp. The two genetically engineered vaccines will be tested on volunteers to determine how well it reacts in a wide range of uninfected individuals. Tests will be conducted at AIDS vaccine centers in Seattle, Baltimore, St. Louis, Nashville, Tenn., and Rochester, N.Y.
Los Angeles Times Articles